Bio-Rad Labs (BIO) Tops Q3 EPS by 85c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $379.47 -0.03%
Revenue Growth %: -0.4%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -0.4%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $2.01, $0.85 better than the analyst estimate of $1.16. Revenue for the quarter came in at $649.7 million versus the consensus estimate of $628.18 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
- Pepsico (PEP) PT Lowered to $161 at BNP Paribas Exane, 'Expect Renewed Calls for Greater Urgency in NA'
- General Mills (GIS) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
